Comments by WHO Europe director, Hans Kluge
The EMA provided an update on Tuesday this week , reiterating what Kluge said above that "the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, outweigh the risks of side effects".

Continue Reading:…

Search Web: WHO Europe director: The benefits of AstraZeneca vaccine outweigh any risks

Recent Posts

Related Listening

December Reports

November Reports

October Reports

September Reports

Chinese (Simplified) ZH-CN English EN French FR German DE Spanish ES